MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    GASTROINTESTINAL SYMPTOMS ARE ASSOCIATED WITH LEFT PREDOMINANT DOPAMINE TRANSPORTER BINDING DEFICIT IN PARKINSON´S DISEASE

    K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, R. Levo, T. Nojonen, M. Eklund, S. Nuuttila, K. Lindholm, E. Pekkonen, J. Joutsa, T. Noponen, T. Ihalainen, V. Kaasinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess correlations between functional gastrointestinal (GI) symptoms and nigrostriatal dopamine transporter imaging asymmetry in Parkinson´s disease (PD) patients. Based on a theory that…
  • MDS Virtual Congress 2021

    Peripheral neuromodulation for the treatment of bladder symptoms associated with Parkinson’s disease

    M. Smith, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To undertake a systematic review of the literature on peripheral neuromodulation techniques for the treatment of bladder symptoms in Parkinson’s disease (PD). Background: Bladder…
  • MDS Virtual Congress 2021

    Evidence of gut dysbiosis in treatment-naïve de novo Parkinson’s disease

    J. Boertien, K. Murtomäki, P. Pereira, S. Vander Zee, A. Slomp, T. Mertsalmi, R. Levo, T. Nojonen, P. Laine, L. Paulin, P. Auvinen, V. Kaasinen, F. Scheperjans, T. van Laar (Groningen, Netherlands)

    Objective: To determine the gut microbiome composition of treatment-naïve de novo Parkinson’s disease (PD) patients. Background: Over fifteen studies have independently demonstrated gut dysbiosis in…
  • MDS Virtual Congress 2021

    Effects of Angiotensin Type 1 Receptor Antagonists on Parkinson’s Disease Progression: an exploratory study in the PPMI database

    L. Udovin, M. Otero-Losada, S. Bordet, G. Chevalier, C. Quarracino, F. Capani, S. Perez-Lloret (Buenos Aires, Argentina)

    Objective: The objective of this study is to analyze the effect of exposure to AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs)  on the clinical…
  • MDS Virtual Congress 2021

    Transcranial direct current stimulation-related changes in postural responses to perturbations are not influenced by baseline clinical characteristics in Parkinson’s disease.

    V. Beretta, R. Vitório, D. Orcioli-Silva, N. Conceição, P. Nóbrega-Sousa, M. Pereira, L. Gobbi (Rio Claro, Brazil)

    Objective: To investigate the association between clinical characteristics and transcranial direct current stimulation (tDCS)-related changes in postural responses to external perturbations in people with Parkinson’s…
  • MDS Virtual Congress 2021

    Effectiveness of an intensive and structured therapy (LSVT-BIG) in comparison to conventional therapy for people with Parkinson’s disease in Singapore.

    D. Maniam, JQ. Yong, V. Tan (Singapore, Singapore)

    Objective: The aim of the study was to investigate if Lee Silverman Voice Therapy BIG (LSVT)-BIG®  programme was more effective than conventional physiotherapy for People…
  • MDS Virtual Congress 2021

    Validity and Reliability of Timed Get-Up and Go Test and Unified Parkinson’s disease Rating Scales on Parkinson ’s disease

    T. T (Bangalore, India)

    Objective: This study is an attempt to find the inter-rater and intra-rater reliability of both timed up and go test and unified Parkinson’s rating scale.…
  • MDS Virtual Congress 2021

    People living with Parkinson’s disease during the COVID-19 Pandemic: A cross-sectional survey of the Canadian experience

    M. Mckeown, T. Mestre, E. Crighton (Ottawa, Canada)

    Objective: To explore the how the COVID-19 pandemic has changed healthcare experiences for people living with Parkinson’s disease (PwP) in Canada. Background: Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Freezing of gait in Parkinson’s disease: A 4-item FOG-Quick questionnaire assessment

    W. Phuenpathom, O. Phokaewvarangkul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To translate and validate a Thai language version of the FOG-Q. In addition, to develop a short-version 4-item question or FOG-Quick questionnaire was developed.…
  • MDS Virtual Congress 2021

    Outcomes of Gene therapy and Subsequent Deep Brain Stimulation for Parkinson’s Disease

    Y. Chintaluru, J. Thomspon, P. David Gerecht, S. Ojemann, D. Kern (Aurora, USA)

    Objective: The purpose of this study is to determine the outcomes of patients who received GAD gene therapy treatment and subsequently underwent DBS for Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 538
  • 539
  • 540
  • 541
  • 542
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley